The Pharma and Biotech Patent Litigation Summit

We are delighted to be returning to Amsterdam as a Platinum Sponsor of the Patent Litigation Europe Conference 2027.

Building on the success of previous years, the conference once again brings together the Pharma & Biotech Patent Litigation Summit and the Tech & Innovation Patent Litigation Conference, creating a unique platform for exploring the growing convergence of life sciences, technology and innovation.

Recognised as one of Europe's leading patent litigation events, the conference attracts senior in-house counsel, private practice lawyers, judges and IP leaders from across a wide range of industries. Delegates will gain insights into the latest developments shaping patent disputes worldwide, including Unified Patent Court (UPC) strategy, cross-border enforcement, SEP and licensing disputes, and the impact of emerging technologies on the patent landscape.

Our team will be actively contributing to the programme, sharing practical experience and strategic perspectives drawn from advising clients on complex patent disputes across Europe and beyond. As the influence of the UPC continues to grow and international litigation strategies become increasingly important, we look forward to connecting with industry peers, exchanging views and helping businesses navigate the opportunities and challenges ahead.

During the conference, Marks & Clerk will host a panel discussion and an interactive roundtable session.

• On Tuesday 19 January, Kamleh Nicola and Dan McGrath will host two roundtables on the topic of 'Preparing Acquired Product Portfolios for Future Disputes'. Each roundtable runs for 45 minutes and start at 16.55. Ensure you sign up for attendance.
• On Wednesday 20 January, Mike Gilbert will be chairing a panel discussing 'Preliminary Injunctions in Focus: Global Trends, Updates and What Litigators Need to Know for 2027'.